Peptidyl-arginine modification

pathway activity — cross-omics
GO:0018195Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-arginine modification pathway is significantly associated with the protein abundance of multiple proteins, with the COAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ZCCHC3, XRN2, and CRNKL1, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-arginine modification activity versus ZCCHC3 in COAD (Pearson r = -0.04).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
COADZCCHC3 →+0.419+0.034<.001<.00136
COADXRN2 →+0.232+0.034<.001<.00135
LSCCCRNKL1 →+0.383+0.059<.001<.00135
GBMTAF4 →+0.252+0.032.002.00935
LSCCTOP2B →+0.298+0.060<.001<.00135
LSCCADNP →+0.259+0.044<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018195 vs ZCCHC3 — COAD

Per-sample scatter of Peptidyl-arginine modification activity vs ZCCHC3 in COAD.

Explore this scatter interactively →

Exploration